Furthermore, the results of Li et al. demonstrated that a decrease in ACE expression and accompanying elevated levels of pro-inflammatory chemokines and cytokines in acute COVID-19 patients as well as in SARS-CoV-2-infected cardiomyocytes were estimated to play an important role in acute COVID-19-affected multiple organ dysfunction [79]. The gene discussed is ACE; the disease is COVID-19.